Enanta Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $1.1M | 149k | 7.56 |
| 2025-03-31 | $880k | 160k | 5.52 |
| 2024-12-31 | $918k | 160k | 5.75 |
| 2024-09-30 | $1.8M | 171k | 10.36 |
| 2024-06-30 | $2.6M | 198k | 12.97 |
| 2024-03-31 | $3.6M | 208k | 17.46 |
| 2023-12-31 | $2.1M | 224k | 9.41 |
| 2023-09-30 | $3.1M | 279k | 11.17 |
| 2023-06-30 | $12M | 290k | 40.44 |
| 2023-03-31 | $12M | 290k | 40.44 |
| 2022-12-31 | $14M | 294k | 46.52 |
| 2022-09-30 | $1.4M | 27k | 51.87 |
| 2022-06-30 | $1.3M | 27k | 47.27 |
| 2022-03-31 | $1.3M | 19k | 71.18 |
| 2021-12-31 | $1.0M | 14k | 74.78 |
| 2021-09-30 | $701k | 12k | 56.81 |
| 2021-06-30 | $543k | 12k | 44.01 |
| 2021-03-31 | $668k | 14k | 49.32 |
| 2020-12-31 | $509k | 11k | 45.78 |
| 2020-09-30 | $509k | 11k | 45.78 |
| 2020-06-30 | $686k | 14k | 50.21 |
| 2020-03-31 | $762k | 15k | 51.43 |
| 2019-12-31 | $803k | 13k | 61.78 |
| 2019-09-30 | $698k | 12k | 60.08 |
| 2019-06-30 | $1.1M | 13k | 84.42 |
| 2019-03-31 | $1.2M | 12k | 95.50 |
| 2018-12-31 | $618k | 8.7k | 70.83 |
| 2018-09-30 | $746k | 8.7k | 85.43 |
| 2018-06-30 | $1.3M | 11k | 115.86 |
| 2018-03-31 | $584k | 7.2k | 80.91 |
| 2017-12-31 | $241k | 4.1k | 58.68 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas